2-(2-Bromophenoxy)-n,n-dimethylacetamide, 95%, 250mg

5-Amino-4-bromopyrimidine, 95.0%, 5g

1H,1H,6H,6H-Perfluorohexyldiacrylate, 95.0%, 5g

1,3,3-Trimethylspiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 97.0%, 1g

4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol, 95.0%, 1g

2-Chloro-4-methylpyrimidin-5-ol, 95.0%, 250mg

methyl 5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoate, 98%, 50mg

3-Nitropyrazole>98.0%(GC)1g

Vinyltrimethylsilane, >95%, 10g

(2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl)-phenyl-methanone, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((3-methylpentan-3-yl)oxy)-4-oxobutanoic acid, 97%, 10g

4-Bromo-1(2H)-isoquinolinone, 96.0%, 5g

5-(4-Pyridinyl)-5-(2-butenyl)-2,7-nonadiene, 250mg